Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-02 07:37:46

expired found date

-

created at

2024-06-06 20:05:43

updated at

2025-12-29 19:29:43

Domain name statistics

length

9

crc

62810

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

23656135

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

1

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

2025-03-26 08:04:28

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

31917

mp size raw text

1933

mp inner links count

1

mp inner links status

20 (imported)

Open Graph

title

Rigel Pharmaceuticals, Inc.

description

site name

Rigel Pharmaceuticals, Inc.

author

updated

2025-12-17 13:42:24

raw text

Rigel Pharmaceuticals, Inc. (RIGL) Investors News & Events Contact Us Home Who We Are Company Overview Management Team Board of Directors Partners Pipeline Pipeline Clinical Trials Investigator Sponsored Research Expanded Access Policy Proprietary Programs IRAK1/4 RIPK1 Partnered Programs BerGenBio Daiichi-Sankyo Grifols Kissei Knight Lilly Medison Novo Nordisk Products Join Our Team Life at Rigel Our Values Benefits Current Openings Investors News & Events Contact Us Developing and Providing Novel Therapies to Enhance Patient Lives Welcome to Rigel Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. About TAVALISSE ® TAVALISSE (fostamatin...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

1427

text words

229

text unique words

146

text lines

66

text sentences

8

text paragraphs

3

text words per sentence

28

text matched phrases

1

text matched dictionaries

3

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

413

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-03-04 17:17:41

sitemap process date

2024-09-10 00:28:26

sitemap first import date

-

sitemap last import date

-